Interested persons can attend without a turn at any of the 400 health posts set up in the Buenos Aires territory.
–
Free vaccination against the coronavirus for people over 30 years of age is in force from this Tuesday in the province of Buenos AireYes, just as Governor Axel Kicillof announced.
“Throughout the province of Buenos Aires those over 30 years of age will be able to access the first dose of free vaccine, concurring with the Identity Document “, without a previous shift, to any of the 400 authorized health posts in the territory, Kicillof advanced this Monday.
He did it through a conference in which he also reported that next week the capacity for inoculated in gastronomic and shopping establishments will be expanded and informed about the opening of the registration for the immunization of adolescents between 13 and 17 years of age with comorbidities.
Today we have several positive news to share.
First of all, tell them that starting tomorrow there is free vaccination of the first dose for people over 30 years of age throughout the Province. pic.twitter.com/y4LV6NnObx
Axel Kicillof (@Kicillofok) July 19, 2021
–
In addition, with more than 10 million vaccinated in the provincial territory, The governor announced that the 40 districts of the Metropolitan Area of Buenos Aires (AMBA) go to Phase 4, due to the sustained decrease in cases below 250 per 100,000 inhabitants in the last 14 days.
The governor also announced that enrollment in the Vaccine plan for adolescents between 13 and 17 years old with comorbidities was opened on Monday.
In the entire province of Buenos Aires, those over 30 years of age will be able to access the first dose of free vaccine.
–
“In the Argentine Republic we have two candidate vaccines for children under 18 years of age but they are not yet approved; they are Moderna and Sinopharm, which is already being applied in their country of origin to children under 18 years of age, but is not approved by the Anmat” , clarify.
At the same time, the opening was announced as of yesterday of “the registration for boys and girls between 13 and 17 years old, particularly those with comorbidities”, so that they are inoculated as soon as the vaccines under study are approved.
– .
